SCHEMBL5524486

SCHEMBL5524486

COC(=O)C=Cc1ccc(OCc2ccccc2)cc1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.58
MAP3K7 O43318 1/20 0.51
TAB1 Q15750 1/20 0.51
BACE1 P56817 4/20 0.50
GSK3B P49841 1/20 0.50
PTGER3 P43115 1/20 0.49
PTGDR Q13258 1/20 0.49
MEN1 O00255 1/20 0.48
HSP90AA1 P07900 1/20 0.48
KMT2A Q03164 1/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
PKM P14618 1/20 0.48
APP P05067 1/20 0.48
MAPT P10636 1/20 0.48
S1PR1 P21453 1/20 0.47
MAOB P27338 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5524484 1.00 HDAC8 (0.58) HDAC8MAP3K7TAB1BACE1GSK3B
SCHEMBL1549368 0.89 MEN1 (0.56) HDAC8PTGER3PTGDRMEN1HSP90AA1
SCHEMBL1549366 0.89 MEN1 (0.56) HDAC8PTGER3PTGDRMEN1HSP90AA1
SCHEMBL9199951 0.89 HDAC8 (0.59) HDAC8MAP3K7TAB1BACE1GSK3B
SCHEMBL4839242 0.88 ALDH1A1 (0.61) HDAC8BACE1GSK3BPTGER3PTGDR
SCHEMBL4839224 0.88 ALDH1A1 (0.61) HDAC8BACE1GSK3BPTGER3PTGDR
SCHEMBL18559977 0.86 HDAC8 (0.69) HDAC8BACE1GSK3BMEN1KMT2A
SCHEMBL865802 0.86 HDAC8 (0.57) HDAC8MAP3K7TAB1BACE1GSK3B
SCHEMBL865803 0.86 HDAC8 (0.57) HDAC8MAP3K7TAB1BACE1GSK3B
SCHEMBL1723809 0.86 HDAC8 (0.57) HDAC8MAP3K7TAB1BACE1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070203155-A1 Compounds And Compositions As Ppar Modulators IRM LLC (BM) 2007-08-30 US disclosed
EP-1748993-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-02-07 EP disclosed
US-20060257987-A1 Ppar modulators ELI LILLY AND COMPANY 2006-11-16 US disclosed
EP-1660428-A1 PPAR MODULATORS ELI LILLY AND COMPANY (US) 2006-05-31 EP disclosed
WO-2005116000-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2005-12-08 WO disclosed
WO-2005019151-A1 PPAR MODULATORS ELI LILLY AND COMPANY (US) 2005-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203155-A1 Compounds And Compositions As Ppar Modulators PPARG, PPARA, PPARD HDAC8 278/4885MAP3K7 1767/4885TAB1 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.